Heartbeam Inc reports results for the quarter ended December 31 - Earnings Summary

• Heartbeam Inc BEAT.OQ reported a quarterly adjusted loss of 14 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -18 cents. The mean expectation of four analysts for the quarter was for a loss of 14 cents per share. Wall Street expected results to range from -15 cents to -10 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Heartbeam Inc's reported EPS for the quarter was a loss of 14 cents​.

• The company reported a quarterly loss of $5.3 million.

• Heartbeam Inc shares had fallen by 38.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.9% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Heartbeam Inc is $4.75, about 69.1% above its last closing price of $1.47

This summary was machine generated from LSEG data March 13 at 09:17 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)